Subjective and Objective Performance of Systane Complete Multi-Dose PF Versus Walgreen's Lubricant Balance

Inclusion Criteria: Subjects are eligible for the study if they meet the following criteria: Note: Ocular criteria must be met in both eyes. * Subjects who currently have mild to moderate symptoms of dry eye as defined by a screening SANDE score of 20-55 inclusive (equivalent to OSDI score of 12 -32).2 * Subjects between the ages of 18-65. * Subjects willing to comply with the prescribed regimen and schedule of eye drops. * Subjects willing to attend all study visits. * Subjects willing to discontinue any current artificial tear use 24 hours prior to the baseline study visit. Exclusion Criteria: If any of the following exclusion criteria are applicable to the subject or either eye, the subject should not be enrolled in the study. * Ocular anterior segment infection, inflammation, abnormality, or active disease. * History of herpetic keratitis or ocular surgery. * Recent (within 1 year) thermal meibomian gland expression procedure including Lipiflow, iLux, or TearCare. * Recent (within 1 year) blepharitis debridement procedure including BlephEx. * Screening SANDE score \> 55 (equivalent to OSDI score of \>32).2 This is indicative of a severe dry eye. * Screening SANDE score \< 20 (equivalent to OSDI score of \<12).2 This is indicative of a clinically normal eye. * Screening non-invasive TBUT \< 2 seconds, or \> 10 seconds.3 * Screening NaFl score \< 3 (clinically normal eye) or \> 10 (severe dry eye).4 * Pregnant or lactating. * Current use of contact lenses. * Any change in eye drop regimen, whether OTC or RX in the last 90 days. The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial.